ARCHIVES

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

This article is from The Cancer Letter archive.

Vol. 07 No. 01 | January 2, 1981

Download PDF Visit The Full Archive

Related Articles

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

Managed Care: Cancer Panel Finds Need “Critical” For Cost, Outcomes Data

September 13, 1996

Mammary Cell/Hormone Report Abstracts From BCTF Meeting

January 16, 1976

NCI To Expand Funds for Cancer Centers, SPOREs, Director Tells House Appropriators

March 29, 2002

House and Senate Appropriators Pledge to Increase Biomedical Research Funding.

March 5, 1999

NCI Cooperative Group, Cancer Center Trials Listed

July 25, 2008